首页> 美国卫生研究院文献>Blood Transfusion >The use of fibrinogen concentrate for the management of trauma-related bleeding: a systematic review and meta-analysis
【2h】

The use of fibrinogen concentrate for the management of trauma-related bleeding: a systematic review and meta-analysis

机译:浓缩纤维蛋白原用于治疗与创伤有关的出血:系统评价和荟萃分析

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Haemorrhage following injury is associated with significant morbidity and mortality. The role of fibrinogen concentrate in trauma-induced coagulopathy has been the object of intense research in the last 10 years and has been systematically analysed in this review. A systematic search of the literature identified six retrospective studies and one prospective one, involving 1,650 trauma patients. There were no randomised trials. Meta-analysis showed that fibrinogen concentrate has no effect on overall mortality (risk ratio: 1.07, 95% confidence interval: 0.83–1.38). Although the meta-analytic pooling of the current literature evidence suggests no beneficial effect of fibrinogen concentrate in the setting of severe trauma, the quality of data retrieved was poor and the final results of ongoing randomised trials will help to further elucidate the role of fibrinogen concentrate in traumatic bleeding.
机译:受伤后的出血与明显的发病率和死亡率有关。在过去的十年中,纤维蛋白原浓缩物在创伤性凝血病中的作用一直是研究的重点,并且在本综述中进行了系统分析。对文献的系统搜索确定了六项回顾性研究和一项前瞻性研究,涉及1,650名创伤患者。没有随机试验。荟萃分析显示,浓缩纤维蛋白原对总死亡率无影响(风险比:1.07,95%置信区间:0.83-1.38)。尽管当前文献证据的荟萃分析表明,纤维蛋白原浓缩物对严重创伤没有有益的作用,但检索到的数据质量较差,正在进行的随机试验的最终结果将有助于进一步阐明纤维蛋白原浓缩物的作用在创伤性出血中。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号